GRANATUM, a collaboration platform for biomedical researchers working on cancer drug studies is now live, according to the Fraunhofer-Institut fuer Angewandte Informationstechnik (FIT), near Bonn, Germany.
The platform was designed to speed up research efforts and help reduce costs by making it easier for scientists from universities, pharmaceutical companies and research institutions to share expertise and experimental data. Through the GRANATUM portal, researchers can "semantically annotate, manage and access biomedical resources, e.g. public databases, digital libraries and archives, online communities and discussions," FIT says in a press release.
Currently, the web portal gives contributing researchers access to about 83 global data sources relating to research and established pharmaceutical agents.
"The GRANATUM Portal will socially connect biomedical research across national boundaries, ease scientific exchange and, for the first time, allow collaboration in formulating hypotheses and testing potential drugs," says Wolfgang Prinz, professor and coordinator of the GRANATUM project and deputy director of the Fraunhofer Institute for Applied Information Technology FIT.
The portal was developed by Fraunhofer FIT and OrbiTeam Software GmbH, with additional funding from the European Commission.